title: [Why rheumatoid arthritis needs cardiologists].
abstract: Rheumatoid arthritis (RA) is associated with a shortened life expectancy. Most premature deaths are caused by cardiovascular (CV) events; therefore it is of importance to consider the increased CV risk when treating RA patients. Traditional CV risk factors cannot fully explain the increased risk but the common understanding is that inflammation significantly contributes to the excess risk observed. Without the use of correction factors commonly used risk calculators underestimate the true CV risk in RA patients. Methotrexate and TNF inhibitors appear to be beneficial with regard to the CV risk. To date there are only few recommendations for interventions in the CV system of RA patients which go beyond those formulated for the general population. The present manuscript summarizes the published evidence concerning the increased CV risk in RA patients.
authors: Academic Research Unit, Interne 2, Allgemeines Krankenhaus Linz, Krankenhausstr. 9, 4020 Linz, Österreich. herwigpi@yahoo.com
authors: H
authors: H
authors: Pieringer
authors: U C
authors: UC
authors: Hoppe
mesh_terms: D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000453:epidemiology* / Q000628:therapy; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000453:epidemiology* / Q000628:therapy; D015897:Comorbidity; D019317:Evidence-Based Medicine; D005858:Germany / Q000453:epidemiology; D006801:Humans; D015995:Prevalence; D018570:Risk Assessment; D015996:Survival Rate
references: Nat Rev Rheumatol. 2010 Aug;6(8):445-51
references: 20647995
references: Semin Arthritis Rheum. 2012 Aug;42(1):17-22
references: 22475246
references: Arthritis Rheum. 2005 Feb;52(2):412-20
references: 15692992
references: Arthritis Res Ther. 2012 Jun 29;14(3):121
references: 22747898
references: Am J Cardiol. 2012 Aug 1;110(3):420-4
references: 22521305
references: Circulation. 2008 Nov 25;118(22):2243-51, 4p following 2251
references: 18997194
references: Rheumatology (Oxford). 2011 Mar;50(3):518-31
references: 21071477
references: Arthritis Rheum. 2012 Sep;64(9):2836-46
references: 22576673
references: Curr Pharm Des. 2012;18(11):1502-11
references: 22364134
references: Rheumatology (Oxford). 2010 Feb;49(2):295-307
references: 19946022
references: Arthritis Care Res (Hoboken). 2011 Apr;63(4):522-9
references: 20957658
references: Ann Rheum Dis. 2009 Sep;68(9):1395-400
references: 18697775
references: Ann Rheum Dis. 2010 Apr;69(4):683-8
references: 19854705
references: BMC Med. 2011 Jan 13;9:4
references: 21232092
references: QJM. 2011 Jan;104(1):13-26
references: 21068083
references: N Engl J Med. 1999 Jan 14;340(2):115-26
references: 9887164
references: Ann Rheum Dis. 2012 Sep;71(9):1496-501
references: 22402144
references: Am J Cardiol. 2011 Nov 1;108(9):1362-70
references: 21855836
references: Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):835-43
references: 22674737
references: Ann Rheum Dis. 2010 Feb;69(2):325-31
references: 19773290
references: Lancet. 2002 Apr 6;359(9313):1173-7
references: 11955534
references: Ann Rheum Dis. 2011 Mar;70(3):482-7
references: 21216812